ClinicalTrials.Veeva

Menu

Surfacer System to Facilitate Access in Venous Occlusions (SAVE)

M

Merit Medical Systems

Status

Completed

Conditions

Venous Thrombosis Upper Extremity
Chronic Venous Thrombosis
Venous Thrombosis Upper Extremity Superficial Veins

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Prospective, single-arm, multicentre, international Registry of the Surfacer System for the treatment of patients with limited or diminishing upper body venous access or pathology impeding standard access methods.The purpose of this post-market Registry is to assess the standard of care and clinical outcomes of the Surfacer System used in clinical routine according to the approved commercial indications.

Full description

This is a prospective, single-arm, multicenter registry of the Surfacer System for patients with limited or diminishing upper body venous access or pathology impeding standard access methods. The need for long term access and lack of availability of veins has led to the development of the Surfacer System, which facilitates reliable and repeatable placement of central venous catheters and restores central venous access. Based on European legislation, this Registry is considered to be an observational study. No additional diagnostic or monitoring procedures as a result of the inclusion are applied to the patients. Available data will be collected in a protected database. Up to 30 patients will be enrolled in 5 sites in Europe. Patients requiring central venous access will be enrolled who meet inclusion and exclusion criteria and for whom the device is indicated.

Enrollment

30 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: patients referred for placement of a central venous catheter

  • patients with limited or diminishing upper body venous access
  • pathology impeding standard access methods
  • signed informed consent

Exclusion Criteria:

  • vulnerable subjects or incapable of giving consent
  • contraindications to central venous access based on treating physicians opinion or standard of care
  • occlusion of the right femoral vein
  • occlusion of the iliac vein
  • occlusion of the inferior vena
  • acute thrombosis within a vessel (IVC, brachiocephalic and subclavian)

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems